MicroRNA-17 promotes cell proliferation and migration in human colorectal cancer by downregulating SIK1

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.2138728055103
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.25651787
   PubMed Web of Science ®Google Scholar
• Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005;23(3):609–618. doi:10.1200/JCO.2005.01.08615659508
   PubMed Web of Science ®Google Scholar
• Bjerkeset T, Morild I, Mork S, Soreide O. Tumor characteristics in colorectal cancer and their relationship to treatment and prognosis. Dis Colon Rectum. 1987;30(12):934–938.3691264
   PubMed Web of Science ®Google Scholar
• Wang WS, Lin JK, Chiou TJ, et al. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer. Hepatogastroent-erology. 2002;49(43):160–164.
   PubMed Web of Science ®Google Scholar
• Slaby O, Svoboda M, Fabian P, et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology. 2007;72(5–6):397–402. doi:10.1159/00011348918196926
   PubMed Web of Science ®Google Scholar
• Pu J, Bai D, Yang X, Lu X, Xu L, Lu J. Adrenaline promotes cell proliferation and increases chemoresistance in colon cancer HT29 cells through induction of miR-155. Biochem Biophys Res Commun. 2012;428(2):210–215. doi:10.1016/j.bbrc.2012.09.12623036199
   PubMed Web of Science ®Google Scholar
• Li ZW, Yang YM, Du LT, et al. Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. Med Oncol. 2014;31(11):1–5. doi:10.1007/s12032-014-0256-5
   Web of Science ®Google Scholar
• Yang X, Hu Y, Liu Y, et al. C14orf28 downregulated by miR-519d contributes to oncogenicity and regulates apoptosis and EMT in colorectal cancer. Mol Cell Biochem. 2017;434(1–2):197–208. doi:10.1007/s11010-017-3049-228455792
   PubMed Web of Science ®Google Scholar
• Huang C, Yu M, Yao X. MicroRNA-17 and the prognosis of human carcinomas: a systematic review and meta-analysis. BMJ Open. 2018;8(5):e018070. doi:10.1136/bmjopen-2017-018070
   PubMed Web of Science ®Google Scholar
• Qian W, Li YX, Liu M, Li X, Hua T. MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells. IUBMB Life. 2012;64(8):697–704. doi:10.1002/iub.109522730212
   PubMed Web of Science ®Google Scholar
• Selvik LKM, Rao S, Steigedal TS, et al. Salt-inducible kinase 1 (SIK1) is induced by gastrin and inhibits migration of gastric adenocarcinoma cells. PLoS One. 2014;9(11):e112485–e112485. doi:10.1371/journal.pone.011248525384047
   PubMed Web of Science ®Google Scholar
• Berdeaux R, Goebel N, Banaszynski L, et al. SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nat Med. 2007;13(5):597. doi:10.1038/nm157317468767
   PubMed Web of Science ®Google Scholar
• Qu C, He D, Lu X, et al. SIK1 silencing promotes HCC progression and WNT/β-catenin activation. J Hepatol. 2016. doi:10.1016/j.jhep.2016.01.005
   PubMed Web of Science ®Google Scholar
• Cheng H, Liu P, Wang ZC, et al. SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis. Sci Signal. 2009;2(80):ra35. doi:10.1126/scisignal.200036919622832
   PubMed Web of Science ®Google Scholar
• Ren ZG, Dong SX, Han P, Qi J. miR-203 promotes proliferation, migration and invasion by degrading SIK1 in pancreatic cancer. Oncol Rep. 2016;35(3):1365–1374. doi:10.3892/or.2015.453426719072
   PubMed Web of Science ®Google Scholar
• Chen JL, Chen F, Zhang TT, Liu NF. Suppression of SIK1 by miR-141 in human ovarian cancer cell lines and tissues. Int J Mol Med. 2016;37(6):1601. doi:10.3892/ijmm.2016.255327081781
   PubMed Web of Science ®Google Scholar
• Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with image. J Biophotonics Int. 2004;11(5–6):36–42.
   Google Scholar
• Rhodes DR, Kalyanasundaram S, Mahavisno V, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007;9(2):166–180.17356713
   PubMed Web of Science ®Google Scholar
• Gaedcke J, Grade M, Jung K, et al. Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas. Genes Chromosomes Cancer. 2010;49(11):1024–1034. doi:10.1002/gcc.2081120725992
   PubMed Web of Science ®Google Scholar
• Kaiser S, Park YK, Franklin JL, et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol. 2007;8(7):R131. doi:10.1186/gb-2007-8-5-r8117615082
   PubMed Web of Science ®Google Scholar
• Skrzypczak M, Goryca K, Rubel T, et al. Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One. 2010;5(10):e13091. doi:10.1371/journal.pone.001309120957034
   PubMed Web of Science ®Google Scholar
• Hong Y, Downey T, Eu KW, Koh PK, Cheah PY. A ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis. 2010;27(2):83–90. doi:10.1007/s10585-010-9305-420143136
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam JW, Bartel D. Predicting effective microRNA target sites in mammalian mRNAs. eLife. 2015;4:e05005.
   Google Scholar
• Dweep H, Gretz NJNM. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods. 2015;12(8):697.
   Google Scholar
• Dweep H, Sticht C, Pandey P, Gretz N. miRWalk–database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. J Biomed Inform. 2011;44(5):839–847. doi:10.1016/j.jbi.2011.05.00221605702
   PubMed Web of Science ®Google Scholar
• Efron B. Logistic regression, survival analysis, and the Kaplan-Meier curve. J Am Stat Assoc. 1988;83(402):414–425. doi:10.1080/01621459.1988.10478612
   Web of Science ®Google Scholar
• Yu J, Ohuchida K, Mizumoto K, Fujita H, Nakata K, Tanaka M. MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. Cancer Biol Ther. 2010;10(8):748–757. doi:10.4161/cbt.10.8.1308320703102
   PubMed Web of Science ®Google Scholar
• Hayashita Y, Osada H, Tatematsu Y, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005;65(21):9628–9632. doi:10.1158/0008-5472.CAN-05-235216266980
   PubMed Web of Science ®Google Scholar
• Hossain A, Kuo MT, Saunders GF. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol. 2006;26(21):8191–8201. doi:10.1128/MCB.00242-0616940181
   PubMed Web of Science ®Google Scholar
• Lichner Z, Saleh C, Subramaniam V, Seivwright A, Prud’homme GJ, Yousef GM. miR-17 inhibition enhances the formation of kidney cancer spheres with stem cell/tumor initiating cell properties. Oncotarget. 2015;6(8):5567. doi:10.18632/oncotarget.v6i825011053
   PubMedGoogle Scholar
• Zhong W, Chen S, Qin Y, et al. Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway. Oncotarget. 2017;8(62):104855–104866. doi:10.18632/oncotarget.2041829285218
   PubMedGoogle Scholar
• Lekun F, Haoran L, Lei W, et al. MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression. Oncotarget. 2014;5(10):2974–2987.
   Google Scholar
• Ma Y, Zhang P, Wang F, et al. Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130. Nat Commun. 2012;3(4):1291.
   Google Scholar
• Maziere P, Enright AJJDDT. Prediction of microRNA targets. 2007;12(11):452–458. Drug Discov Today. doi:10.1016/j.drudis.2007.04.002
   Google Scholar
• Yao YH, Cui Y, Qiu XN, et al. Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells. Chin J Cancer. 2016;35:50. doi:10.1186/s40880-016-0113-327266881
   PubMedGoogle Scholar
• Selvik LK, Rao S, Steigedal TS, et al. Salt-inducible kinase 1 (SIK1) is induced by gastrin and inhibits migration of gastric adenocarcinoma cells. PLoS One. 2014;9(11):e112485. doi:10.1371/journal.pone.011248525384047
   PubMed Web of Science ®Google Scholar
• Jumpertz S, Hennes T, Asare Y, Schütz AK, Bernhagen J. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells. Cell Signal. 2017;34:38. doi:10.1016/j.cellsig.2017.02.01328229932
   PubMed Web of Science ®Google Scholar
• Hlubek F, Brabletz T, Budczies J, Pfeiffer S, Jung A, Kirchner T. Heterogeneous expression of Wnt/β-catenin target genes within colorectal cancer. Int J Cancer. 2007;121(9):1941–1948. doi:10.1002/ijc.2291617631641
   PubMed Web of Science ®Google Scholar
• Li H, Bian C, Liao L, Li J, Zhao RC. miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1. Breast Cancer Res Treat. 2011;126(3):565–575. doi:10.1007/s10549-010-0954-4
   Google Scholar